Media Summary: These standards will hopefully discourage the now common practice of relegating Presented By: Harita Veereshlingam, PhD Speaker Biography: Harita Veereshlingam is a Senior Product Application Scientist in ... Project failure due to lack of clinical efficacy during development remains an issue and can in part be attributed to inadequate ...

Webinar Cancer Target Discovery And Validation - Detailed Analysis & Overview

These standards will hopefully discourage the now common practice of relegating Presented By: Harita Veereshlingam, PhD Speaker Biography: Harita Veereshlingam is a Senior Product Application Scientist in ... Project failure due to lack of clinical efficacy during development remains an issue and can in part be attributed to inadequate ... Industry expert Yair Benita shows an example of Dr Olivia Rossanese describes how the ICR's new So just as a summary http uc attacks growing comprehensive

... discusses the importance of repeatability and robustness in science and common pitfalls in preclinical Cindy L. O'Bryant, PharmD, BCOP, FHOPA, FCCP. Look at your therapeutic strategy through the lens of energy metabolism. Identify new therapeutic While progress has been made in understanding the mechanism of In this presentation, from the 2021 Spatial Biology Europe Congress, Gavin Gordon, Ph.D., Vice President, Clinical Market ...

Photo Gallery

[WEBINAR] Cancer Target Discovery and Validation
OCCPR Webinar: Translational Discovery and Validation Using Multi-omics Data from ER+ Breast Tumors
Cancer Discovery and Preclinical Validation Using Patient-Derived Xenografts
Preclinical cancer-target validation: How not to be wrong
Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers
Cancer Drug Discovery: A Synthetic Lethality Approach Using Integrated Platforms
MDC Connects: Target Validation and Efficacy
Target-Based Drug Discovery in Cancer Research
Webinar: SAVI and the use of ultra-large DB's in anti-cancer Drug Discovery. #SAVI #Chemspace
Target weaknesses in cancer | Identifying new targets
Webinar: Label-free Target Identification to Unleash Drug Discovery
New Technologies for Target Discovery and Validation
View Detailed Profile
[WEBINAR] Cancer Target Discovery and Validation

[WEBINAR] Cancer Target Discovery and Validation

In this

OCCPR Webinar: Translational Discovery and Validation Using Multi-omics Data from ER+ Breast Tumors

OCCPR Webinar: Translational Discovery and Validation Using Multi-omics Data from ER+ Breast Tumors

This

Cancer Discovery and Preclinical Validation Using Patient-Derived Xenografts

Cancer Discovery and Preclinical Validation Using Patient-Derived Xenografts

During this presentation of the

Preclinical cancer-target validation: How not to be wrong

Preclinical cancer-target validation: How not to be wrong

These standards will hopefully discourage the now common practice of relegating

Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers

Genetic technologies for the discovery and verification of cancer immunotherapy biomarkers

Presented By: Harita Veereshlingam, PhD Speaker Biography: Harita Veereshlingam is a Senior Product Application Scientist in ...

Cancer Drug Discovery: A Synthetic Lethality Approach Using Integrated Platforms

Cancer Drug Discovery: A Synthetic Lethality Approach Using Integrated Platforms

Register for this

MDC Connects: Target Validation and Efficacy

MDC Connects: Target Validation and Efficacy

Project failure due to lack of clinical efficacy during development remains an issue and can in part be attributed to inadequate ...

Target-Based Drug Discovery in Cancer Research

Target-Based Drug Discovery in Cancer Research

Industry expert Yair Benita shows an example of

Webinar: SAVI and the use of ultra-large DB's in anti-cancer Drug Discovery. #SAVI #Chemspace

Webinar: SAVI and the use of ultra-large DB's in anti-cancer Drug Discovery. #SAVI #Chemspace

Space

Target weaknesses in cancer | Identifying new targets

Target weaknesses in cancer | Identifying new targets

Dr Olivia Rossanese describes how the ICR's new

Webinar: Label-free Target Identification to Unleash Drug Discovery

Webinar: Label-free Target Identification to Unleash Drug Discovery

Label-free

New Technologies for Target Discovery and Validation

New Technologies for Target Discovery and Validation

So just as a summary http uc attacks growing comprehensive

Profiling the cell surface of cancer cell lines for biomarker/drug target discovery

Profiling the cell surface of cancer cell lines for biomarker/drug target discovery

Presented at

William G. Kaelin, Jr.: Preclinical Cancer Target Validation: How to Avoid Being Wrong

William G. Kaelin, Jr.: Preclinical Cancer Target Validation: How to Avoid Being Wrong

... discusses the importance of repeatability and robustness in science and common pitfalls in preclinical

Drug Discovery: The Pathway to FDA Approval

Drug Discovery: The Pathway to FDA Approval

Cindy L. O'Bryant, PharmD, BCOP, FHOPA, FCCP.

Target Identification and Validation with Cellular Metabolism Video

Target Identification and Validation with Cellular Metabolism Video

Look at your therapeutic strategy through the lens of energy metabolism. Identify new therapeutic

Biochemistry Focus ECR webinar series - Developments in Drug discovery

Biochemistry Focus ECR webinar series - Developments in Drug discovery

The

Unlocking the potential of ultra-low frequency variant identification for cancer research

Unlocking the potential of ultra-low frequency variant identification for cancer research

The

Oncology & Immuno Oncology Precision Medicine From Hit Finding to Pre Clinical Candidate Selection

Oncology & Immuno Oncology Precision Medicine From Hit Finding to Pre Clinical Candidate Selection

While progress has been made in understanding the mechanism of

A Spatial Biology Approach For Biomarker Discovery and Validation in Immuno-Oncology

A Spatial Biology Approach For Biomarker Discovery and Validation in Immuno-Oncology

In this presentation, from the 2021 Spatial Biology Europe Congress, Gavin Gordon, Ph.D., Vice President, Clinical Market ...